Norman Sussman

Norman Sussman

Director Técnico/Científico/I+D en DURECT CORPORATION .

Fortuna: 824 $ al 30/04/2024

71 años
Health Technology
Commercial Services
Consumer Services

Origen de la red de primer grado Norman Sussman.

EntidadTipo de entidadIndustria
Public Company Pharmaceuticals: Major 19
Interferon Sciences, Inc.
6
Extinct Pharmaceuticals: Major 6
2
Subsidiary Biotechnology 2
Hepatix, Inc.
1
Private Company 1

Gráfico Empresas conectadas de segundo grado

Relaciones con varias empresas

Empresas conectadas a Norman Sussman a través de su red personal

EmpresaSectorPersonas relacionadasPuesto principal
ALZA CORPORATION Pharmaceuticals: Major

James Brown

David Hoffmann

Chief Tech/Sci/R&D Officer

Director of Finance/CFO

Alza Development Corp.

David Hoffmann

Director/Board Member

Investment Banks/Brokers

Timothy Papp

Corporate Officer/Principal

SERNOVA CORP. Biotechnology

Mohammad Azab

Director/Board Member

FIVE PRIME THERAPEUTICS, INC. Biotechnology

Gail Maderis

Chief Executive Officer

Miscellaneous Commercial Services

Gail Maderis

Director/Board Member

NOVABAY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Gail Maderis

Director/Board Member

Biotechnology

Gail Maderis

Chairman

The Trustees of Columbia University in The City of New York College/University

Terrence Blaschke

Doctorate Degree

College/University

Timothy Papp

Undergraduate Degree

Investment Managers

Timothy Papp

Corporate Officer/Principal

OPTHEA LIMITED Biotechnology

Judith Robertson

Corporate Officer/Principal

Miscellaneous Commercial Services

Jian Li

Corporate Officer/Principal

Medical Specialties

Michael Arenberg

Founder

Temple University (Pennsylvania) College/University

James H. Kelly

Doctorate Degree

University of California, Berkeley College/University

Gail Maderis

David J. Ellis

Keith L. Lui

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Lawrence M. Gordon

Mark Germain

James H. Kelly

President

Chairman

Chief Executive Officer

PDL BIOPHARMA, INC. Biotechnology

Jon Saxe

Peter García

President

Director of Finance/CFO

University of Denver College/University

Terrence Blaschke

Michael Arenberg

Undergraduate Degree

Graduate Degree

The University of Colorado College/University

Anthony F. Purchio

David Hoffmann

Doctorate Degree

Undergraduate Degree

New York University School of Law College/University

Jon Saxe

Mark Germain

Graduate Degree

Graduate Degree

College/University

Jian Li

Masters Business Admin

Biotechnology

Gail Maderis

Director/Board Member

Pharmaceuticals: Major

Gail Maderis

Director/Board Member

Miscellaneous Commercial Services

Gail Maderis

Director/Board Member

Termeer Foundation

Gail Maderis

Director/Board Member

Investment Trusts/Mutual Funds

Gail Maderis

Director/Board Member

ALLARITY THERAPEUTICS, INC. Pharmaceuticals: Major

Gail Maderis

Director/Board Member

Miscellaneous Commercial Services

Gail Maderis

Director/Board Member

Harvard Business School College/University

Gail Maderis

Corporate Officer/Principal

Miscellaneous Commercial Services

Jian Li

Corporate Officer/Principal

Guangdong University of Foreign Studies College/University

Jian Li

Undergraduate Degree

Stanford University School of Medicine College/University

Terrence Blaschke

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Timothy Papp

Masters Business Admin

PYRAMISA HOTELS & RESORTS Hotels/Resorts/Cruise lines

Mohammad Azab

Director/Board Member

LISATA THERAPEUTICS, INC. Pharmaceuticals: Major

Mohammad Azab

Director/Board Member

Investment Banks/Brokers

Timothy Papp

Corporate Officer/Principal

MOLECULAR TEMPLATES, INC. Biotechnology

David Hoffmann

Director/Board Member

Estadísticas

Internacional

Estados Unidos 40
Francia 3
Canadá 2
Australia 2
Reino Unido 2

Sectorial

Health Technology 20
Consumer Services 16
Commercial Services 7
Finance 4
Technology Services 2

Operativa

Director/Board Member 89
Corporate Officer/Principal 47
Independent Dir/Board Member 28
Chairman 21
President 20
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA